Apeksha Sridhar

Apeksha Sridhar

Auto-generated profile, based on publicly available information

Apeksha Sridhar

Susan Samueli Integrative Health Institute, School of Medicine, University of California Irvine, Irvine, CA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2026 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
DNDing Quan Ng
Ding Quan Ng
MHMatthew Heshmatipour
Matthew Heshmatipour
JTJulia Trudeau
Julia Trudeau
ASApeksha Sridhar
Apeksha Sridhar
BPBrock Pluimer
Brock Pluimer
ACAlexandre Chan
Alexandre Chan
Background: We conducted a randomized, double-blinded pilot trial to compare the impact of two electroacupuncture (EA) regimens on co-occurring neuropsychiatric symptoms among breast cancer survivors (BCS). Methods: BCS who self-reported cognitive impairment, fatigue, insomnia, or psychological distress were randomized (1:1) to receive ten weekly EA to target either neuropsychiatric-specific (nEA) or non-neuropsychiatric-specific (sEA) acupoints. Primary endpoints were the within-group pre-post effect sizes (Glass’s Δ) in symptom severities, adjusted for multiple comparisons (p-adjusted). Outcomes were assessed using neurocognitive tests (CANTAB®), PROs (FACT-Cog, MFSI-SF, EORTC QLQ-C30), plasma biomarkers, and neuroimaging. Responders were defined by reliable change index (for objective cognition) or MCID (for PROs). Results: Thirty-five were recruited, with 30 (86%) completing all sessions. The mean (±SD) age was 58.2 (±12.2) years, and 86% reported co-occurring symptoms. Following treatment, the nEA group demonstrated significant improvements in attention (T3: Δ = 0.562, T4: Δ = 0.708, both p-adjusted < 0.05) and distress (T3: Δ = 0.764, T4: Δ = 0.711, both p-adjusted < 0.05). More responders were observed after nEA treatment for objective cognition (42.9% vs 12.5%) and distress (50% vs 37.5%). nEA-treated participants showed increased gray matter volume compared to sEA (p = 0.033), which positively correlated with better attention function (r = 0.69, p = 0.020). nEA-related improvements in memory and response speed were associated with reduced connectivity in the Default Mode Network (DMN–SFG, r=-0.93, p < 0.01) and increased connectivity in the Dorsal Attention Network (DAN–SMG, r = 0.86, p < 0.001), respectively. All adverse events were grade 2 or lower. Conclusions: EA targeting neuropsychiatric-specific acupoints suggests improvements in cognition and distress symptoms in BCS, warranting validation in larger, multicenter trials. Clinicaltrials.gov: NCT05283577.

10 January 2026 in Communications Medicine
Verified
Journal Article
Open access
PDF file
ASApeksha Sridhar
Apeksha Sridhar
IMIshtiaq Mawla
Ishtiaq Mawla
EIEric Ichesco
Eric Ichesco
BPBrock Pluimer
Brock Pluimer
SHSteven E. Harte
Steven E. Harte
RHRichard Harris
Richard Harris
Background: Chronic pain may involve both nociceptive pain driven by peripheral tissue damage and nociplastic pain reflecting central nervous system dysregulation, as in fibromyalgia. Electroacupuncture has been shown to modulate these pathways, but the underlying brain mechanisms remain unclear. This study investigated how electroacupuncture influences nociceptive-initiated and centrally maintained pain via changes in brain activation and functional connectivity. Methods: In this randomized controlled trial (NCT02064296), female adults with fibromyalgia received either electroacupuncture (n = 19) or sham treatment with inactive laser stimulation (n = 25) over four weeks. Changes in brain activation and connectivity during evoked pressure-pain stimulation were assessed using functional magnetic resonance imaging before and after treatment. Here, we present a secondary analysis of data from the trial. Clinical outcomes assessed include pressure-pain tolerance and widespread pain, and analyses tested whether brain measures mediated treatment-related effects. Results: Here we show that in the electroacupuncture group, reductions in widespread pain are associated with increases in pressure-pain tolerance. This relationship is mediated by greater activation of the primary somatosensory cortex and stronger connectivity between somatosensory and insular regions, consistent with a bottom-up mechanism linking peripheral nociceptive-initiated input to central nociplastic pain modulation. In contrast, the sham group shows reductions in widespread pain linked to decreased precuneus activity and precuneus–insula connectivity, consistent with a top-down process. Conclusions: Electroacupuncture and sham treatments engage distinct neural pathways to influence pain perception. These findings highlight that electroacupuncture modulates nociceptive-initiated and nociplastic pain through a bottom-up sensory pathway, whereas sham treatment engages top-down control. This mechanistic dissociation may inform patient selection and optimization of acupuncture-based therapies for chronic pain.

23 November 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
ASApeksha Sridhar
Apeksha Sridhar
RKR. Joanne Jao Keehn
R. Joanne Jao Keehn
MWMolly Wilkinson
Molly Wilkinson
YGYangfeifei Gao
Yangfeifei Gao
MOMichael Olson
Michael Olson
RMRalph-Axel Müller
Ralph-Axel Müller
Autism spectrum disorder (ASD) is highly heterogeneous in etiology and clinical presentation. Findings on intrinsic functional connectivity (FC) or task-induced FC in ASD have been inconsistent including both over- and underconnectivity and diverse regional patterns. As FC patterns change across different cognitive demands, a novel and more comprehensive approach to network architecture in ASD is to examine the change in FC patterns between rest and task states, referred to as reconfiguration. This approach is suitable for investigating inefficient network connectivity that may underlie impaired behavioral functioning in clinical disorders. We used functional magnetic resonance imaging (fMRI) to examine FC reconfiguration during lexical processing, which is often affected in ASD, with additional focus on interindividual variability. Thirty adolescents with ASD and a matched group of 23 typically developing (TD) participants completed a lexicosemantic decision task during fMRI, using multiecho-multiband pulse sequences with advanced BOLD signal sensitivity and artifact removal. Regions of interest (ROIs) were selected based on task-related activation across both groups, and FC and reconfiguration were compared between groups. The ASD group showed increased interindividual variability and overall greater reconfiguration than the TD group. An ASD subgroup with typical performance accuracy (at the level of TD participants) showed reduced similarity and typicality of FC during the task. In this ASD subgroup, greater FC reconfiguration was associated with increased language skills. Findings suggest that intrinsic functional networks in ASD may be inefficiently organized for lexicosemantic decisions and may require greater reconfiguration during task processing, with high performance levels in some individuals being achieved through idiosyncratic mechanisms. Highlights: FC reconfiguration is a comprehensive approach to examining network architecture Functional networks are inefficiently organized for lexicosemantic decisions in ASD ASD may require greater reconfiguration during task processing Some ASD individuals achieve high performance through idiosyncratic mechanisms

14 August 2026 in Pain Reports
Verified
Journal Article
Open access
SHSteven E. Harte
Steven E. Harte
LALesley M. Arnold
Lesley M. Arnold
EIEric Ichesco
Eric Ichesco
SPScott Peltier
Scott Peltier
Kim M. CecilKim M. Cecil
Kim M. Cecil
RHRichard Harris
Richard Harris
Objective: This exploratory, 2-site phase 2 clinical trial investigated whether neuroimaging biomarkers could demonstrate the analgesic potential of NYX-2925, a novel N -methyl- d -aspartate receptor modulator, in women with fibromyalgia. Methods: Twenty-two participants completed sequential 2-week treatment periods: placebo, 20 mg NYX-2925, and 200 mg NYX-2925. Resting state functional connectivity magnetic resonance imaging and proton magnetic resonance spectroscopy were performed during the second week of each period. Results: The 200 mg dose produced statistically significant improvements in pain, fatigue, fibromyalgia severity, and function compared with placebo. Neuroimaging revealed that NYX-2925 reduced glutamate and glutamine/total creatine ratios in the dorsal anterior cingulate cortex at rest ( P = 0.032) and in the posterior insular cortex after evoked pain ( P = 0.039). Notably, higher baseline pain-evoked glutamate and glutamine levels in the pIns predicted greater reductions in experimental pain sensitivity at both the 20 mg ( r = 0.55; P = 0.029) and 200 mg ( r = 0.51; P = 0.046) doses. The 20 mg dose also reduced resting state connectivity between the dorsal anterior cingulate cortex and both primary somatosensory cortex ( P = 0.030 family-wise error) and precuneus ( P = 0.031 family-wise error). NYX-2925 demonstrated good tolerability and safety. Conclusion: These exploratory findings suggest that NYX-2925 modulates excitatory neurometabolic activity and functional connectivity in pain-processing networks, with modest accompanying clinical improvement. A subsequent larger randomized trial did not confirm clinical benefit, so the present results should be regarded as hypothesis-generating and require independent replication. We discuss the value, and the limits, of neuroimaging measures for mechanistic drug development and personalized pain medicine.

31 October 2025 in Research Square
Verified
Preprint
Open access
PDF file
ASApeksha Sridhar
Apeksha Sridhar
IMIshtiaq Mawla
Ishtiaq Mawla
EIEric Ichesco
Eric Ichesco
BPBrock Pluimer
Brock Pluimer
SHSteven Harte
Steven Harte
RHRichard Harris
Richard Harris
Chronic pain may arise from overlapping pain pathways, including nociceptive pain driven by peripheral tissue damage and nociplastic pain arising from central nervous system dysregulation, as seen in fibromyalgia. This study investigated how electroacupuncture (EA) produces analgesia by modulating these pain mechanisms via changes in brain activation and functional connectivity (FC). Following 4-weeks of EA, reductions in widespread pain, a marker of central nociplastic pain, were associated with increased pressure-pain tolerance to peripheral nociceptive stimuli. This nociplastic-nociceptive relationship was mediated by increased somatosensory activation (S1) and S1–insula FC, suggesting that EA operates through a “bottom-up” mechanism of action: afferent input from the needle modulates central sensory networks to reduce nociplastic pain. In contrast, the sham group reduced widespread pain via a “top-down” centrally inhibiting mechanism, characterized by decreased precuneus activation and reduced precuneus–insula FC. These findings elucidate contributions of bottom-up versus top-down circuits in mediating pain relief.